Chitosan as an adjuvant for parenterally administered inactivated influenza vaccines
Author:
Publisher
Springer Science and Business Media LLC
Subject
Virology,General Medicine
Link
http://link.springer.com/content/pdf/10.1007/s00705-008-0047-4.pdf
Reference20 articles.
1. Belshe RB, Gruber WC, Mendelman PM, Cho I, Reisinger K, Block SL, Wittes J, Iacusio D, Piedra P, Treanor J, King I, Kotloff K, Bernstein DI, Hayden FG, Zangwill K, Yan L, Wollf M (2000) Efficacy of vaccination with live attenuated, cold adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine. J Pediatr 136:168–175
2. Couch R (2000) Influenza: prospects for control. Ann Intern Med 133:992–998
3. De Jong J, Beyer W, Palache A, Rimmelzwaan G, Osterhaus A (2000) Mismatch between the 1997/1998 influenza vaccine and the major epidemic A/H3N2 virus strain as the cause of an inadequate vaccine-induce antibody response to this strain in the elderly. J Med Virol 61:94–99
4. Felt O, Buri P, Curny R (1998) Chitosan, a unique polysaccharide for drug delivery. Drug Dev Ind Pharm 24:979–993
5. Gluck U, Gebbers J, Gluck R (1999) Phase 1 evaluation intranasal virosomal influenza vaccine with and without E. coli heat-labile toxin in adult volunteers. J Virol 73:7780–7786
Cited by 48 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Applications of Chitosan in Prevention and Treatment Strategies of Infectious Diseases;Pharmaceutics;2024-09-13
2. Glycovaccinology: The design and engineering of carbohydrate-based vaccine components;Biotechnology Advances;2023-11
3. Inhalable chitosan-based hydrogel as a mucosal adjuvant for hydroxychloroquine in the treatment for SARS-CoV-2 infection in a hamster model;Journal of Microbiology, Immunology and Infection;2023-10
4. Evolution of Adjuvants Across the Centuries;Plotkin's Vaccines;2023
5. The evolution of the global COVID-19 epidemic in Morocco and understanding the different therapeutic approaches of chitosan in the control of the pandemic;Polymer Bulletin;2022-11-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3